SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-19-006694
Filing Date
2019-04-08
Accepted
2019-04-08 06:08:23
Documents
5
Effectiveness Date
2019-04-08

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A dmtp20190325_defa14a.htm DEFA14A 17412
2 n4.jpg GRAPHIC 18778
3 n3.jpg GRAPHIC 54447
4 n2.jpg GRAPHIC 156574
5 n1.jpg GRAPHIC 108271
  Complete submission text file 0001437749-19-006694.txt   484021
Mailing Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36291 | Film No.: 19736321
SIC: 2834 Pharmaceutical Preparations